Preventing Anaphylaxis With Acalabrutinib

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2021
Food allergy is a potentially life-threatening condition, and its prevalence continues to increase despite public health efforts. There are currently no known therapies that can reliably prevent food-induced anaphylaxis. This is an open-label study designed to determine the ability acalabrutinib to prevent signs and symptoms of anaphylaxis during an oral food challenge in food-allergic adults.
Epistemonikos ID: ad6e5664a47a030b05942a39b3255127222c8d0c
First added on: May 09, 2024